A few weeks ago, I attended the annual Oregon Dental Conference in Portland. One of the most interesting topics discussed at the conference is the impact of marijuana (cannabis), its active ingredient tetrahydrocannabinol (THC), and cannabidiol (CBD), in the medical and dental industries.
As many in healthcare may know already, cannabis is classified as a Schedule I substance, and according to the Drug Enforcement Administration, "has no currently accepted medical use." However, in the last few years...